Relmada Therapeutics, Inc. (RLMD)
Nasdaq: RLMD · Pharmaceutical Preparations · Coral Gables, FL · filing with the SEC since 2012
Who owns Relmada Therapeutics, Inc.
As filed with the SECHolders of 5% or more
6
Janus Henderson Group PLC holds 10.1% of Common Stock, as its SCHEDULE 13G filed Feb 6, 2026 says.
Directors and officers
7
report now, of 12 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Janus Henderson Group PLC
SCHEDULE 13G · filed Feb 6, 2026 · Common Stock
Squadron Master Fund LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, $0.001 par value per share · 9.9% in Feb 17, 2026
Blackrock, Inc.
SCHEDULE 13G · filed Jul 29, 2026 · Common Stock
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G · filed Jun 9, 2026 · Common Stock, $0.001 par value per share
Spruce Street Capital LP
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, par value $0.001 per share
Commodore Capital LP
SCHEDULE 13G · filed May 4, 2026 · Common stock, $0.001 par value per share
Ikarian Capital, LLC
SCHEDULE 13G · filed Nov 14, 2025 · Common Stock, par value $0.001 par value per share · reported falling below 5%
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed May 13, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.82% in Feb 12, 2026
Millennium Management LLC
SCHEDULE 13G · filed Jun 22, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%
What RLMD reports owning in othersstakes of 5% or more, and other ties
Relmada Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
10purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$4.0Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 12 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Traversa Sergio | Chief Executive Officer | 0 | $0 | 0 | 4 | $1.5M |
| Shenouda Maged | Chief Financial Officer | 0 | $0 | 0 | 4 | $2.0M |
| Kelly Paul Edward | COO | 0 | $0 | 0 | 1 | $200,000 |
| Ence Chuck | CA and CO | 0 | $0 | 0 | 1 | $300,000 |